Liz Dallimore says the independent MCAo data marks a pivotal confirmation of ARG 007’s neuroprotective activity and sharpens the company’s focus on dose strategy for future clinical development.
Chief Executive Officer Cliff Fitzhenry notes that the confirmation of near-surface rutile and deepening flake graphite horizons marks a transformational phase in understanding the scale and quality of the Central Rutile Project.
Shanthar Pathmanathan explains how Chariot Corporation’s new small scale mining agreement sets a clear path toward near term Nigerian lithium production.
Osmond Resources Anthony Hall says new drilling confirms further high grade titanium, zircon and rare earths at Orion.
Altech Batteries Managing Director Iggy Tan says the unsolicited engagement from one of the world’s largest battery manufacturers marks a pivotal validation point for the company’s Silumina Anodes technology.
Noronex Managing Director and Chief Executive Officer Victor Rajasooriar says the $4.5 million Witvlei divestment is a deliberate step in focusing the company on its highest-priority copper and uranium targets
Managing Director Edmund Ainscough describes the Lady Herial resource update as a pivotal milestone that positions Lunnon Metals for a streamlined transition into production.
Dr David Foster says the FDA’s confirmation of Galidesivir’s regulatory pathway marks a major milestone for Island Pharmaceuticals.
Kerrie Matthews says the new Columbia University collaboration places Locksley Resources at the forefront of U.S. driven innovation in rare earth and antimony processing as federal support for domestic critical minerals accelerates.
Ariana Resources has returned multiple high-grade gold intercepts from the Tavsan North Zone drilling program, reinforcing the potential for resource growth ahead of the 2026 JORC update.